We are live on ! Find out more
TCS

Texas Children's Portfolio holdings

AUM $20.5M
1-Year Est. Return 51.2%
This Fund
S&P 500
This Quarter Est. Return
-20.96%
1 Year Est. Return
-51.2%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.7M
AUM Growth
–
Cap. Flow
+$74.9M
Cap. Flow %
104.36%
Top 10 Hldgs %
87.62%
Holding
41
New
41
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BSM icon
Black Stone Minerals
BSM
+$38.4M
2
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$16.9M
3
OIH icon
VanEck Oil Services ETF
OIH
+$2.68M
4
ABMD
Abiomed Inc
ABMD
+$1.27M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.14M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Energy 58.12%
2 Healthcare 17.13%
3 Technology 0.91%
4 Consumer Staples 0.13%
5 Financials 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSM icon
1
Black Stone Minerals
BSM
$3.04B
$35.1M 48.96%
+2,268,592
New +$38.4M
XOP icon
2
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.48B
$12.8M 17.85%
+120,651
New +$16.9M
EPD icon
3
Enterprise Products Partners
EPD
$82.6B
$6.56M 9.14%
+281
New +$7.52K
OIH icon
4
VanEck Oil Services ETF
OIH
$2.05B
$1.9M 2.65%
+6,779
New +$2.68M
ABMD
5
DELISTED
Abiomed Inc
ABMD
$1.19M 1.65%
+3,646
New +$1.27M
INCY icon
6
Incyte
INCY
$23.4B
$1.09M 1.52%
+17,142
New +$1.11M
ONC
7
BeOne Medicines Ltd
ONC
$32.4B
$1.08M 1.5%
+7,682
New +$1.02M
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
$1M 1.4%
+70,435
New +$1.07M
ACAD icon
9
Acadia Pharmaceuticals
ACAD
$4.38B
$947K 1.32%
+58,546
New +$1.14M
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$893K 1.25%
+9,176
New +$1.08M
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$11.5B
$770K 1.07%
+9,047
New +$861K
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$745K 1.04%
+13,147
New +$825K
WVE icon
13
Wave Life Sciences
WVE
$1.12B
$726K 1.01%
+17,279
New +$768K
UTHR icon
14
United Therapeutics
UTHR
$22.7B
$619K 0.86%
+5,686
New +$659K
FOLD
15
DELISTED
Amicus Therapeutics
FOLD
$551K 0.77%
+57,542
New +$633K
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
$538K 0.75%
+14,751
New +$604K
SAGE
17
DELISTED
Sage Therapeutics
SAGE
$533K 0.74%
+5,563
New +$637K
MRUS
18
DELISTED
Merus
MRUS
$523K 0.73%
+37,380
New +$541K
GHDX
19
DELISTED
Genomic Health, Inc.
GHDX
$518K 0.72%
+8,035
New +$563K
NBIX icon
20
Neurocrine Biosciences
NBIX
$17.2B
$460K 0.64%
+6,438
New +$617K
SLDB icon
21
Solid Biosciences
SLDB
$858M
$443K 0.62%
+1,103
New +$519K
AAPL icon
22
Apple
AAPL
$4.9T
$434K 0.61%
+11,000
New +$533K
IMMU
23
DELISTED
Immunomedics Inc
IMMU
$406K 0.57%
+28,448
New +$565K
WMT icon
24
Walmart Inc
WMT
$909B
$82K 0.11%
+2,640
New +$84.6K
ADBE icon
25
Adobe
ADBE
$94.3B
$79K 0.11%
+350
New +$84.5K
1
2

Similar funds

JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
AF
AMG Funds Stamford, Connecticut $20M AUM 3.75% 1-Year Est. Return
C
Cerebellum San Francisco, California $21.5M AUM
BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
IAM
ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return
SC
Schooner Capital Vero Beach, Florida $23.2M AUM 17.29% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

Texas Children's's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Texas Children's, which disclosed 41 positions worth $71.7M. Its ten largest holdings account for 88% of the portfolio.

Its largest position is Black Stone Minerals: 2,268,592 shares worth $35.1M.

By sector, the portfolio is most concentrated in Energy at 58% of assets, followed by Healthcare and Technology.

  • Texas Children's's largest Q4 2018 buy was Black Stone Minerals: 2,268,592 shares worth $35.1M.
  • Texas Children's's ten largest holdings make up 88% of its $71.7M portfolio in Q4 2018.
  • Texas Children's disclosed 41 positions in Q4 2018, its first 13F filing on record.

Based on Texas Children's's 13F filing for Q4 2018, filed 14 Feb 2019.